After assessing the feasibility of an in-person meeting, ISOQOL leadership determined that this year’s meeting will once again be virtual. Stay tuned for future announcements related to the Annual Conference.

It is our hope that by transitioning this event to a virtual format, ISOQOL will continue bringing together researchers, students, clinicians, regulatory agency professionals, industry representatives, and patient research partners from around the world while maintaining the safety of all attendees.

ISOQOL staff and Annual Conference Chairs are in the process of redesigning the program. We appreciate your continued understanding as ISOQOL works to finalize plans for its second virtual Annual Conference. The website will be continually updated with specifics of the virtual event, and membership will receive email updates on the Annual Conference as usual. 

If you have any questions regarding involvement in the 28th Annual Conference, please do not hesitate to email us at and a staff member will help you directly.

Abstract Submissions – Deadline Extended

Abstracts are now open through 16 April for 2021 Annual Conference oral, oral brief, and poster presentations. Visit the conference website for further information, specific guidelines for each presentation type, and details on how to submit.

Travel Scholarships

Although the conference is virtual for 2021, scholarships will be awarded to select student, new investigator, developing country and patient applicants to offset the cost of participation in the Virtual Annual Conference. Applications for travel scholarships are open now through 16 April 2021Visit the conference website to learn more.

The International Society for Quality of Life Research (ISOQOL) is a global community of researchers, clinicians, health care professionals, industry professionals, consultants, and patient research partners advancing health related quality of life research (HRQL).

Together, we are creating a future in which patient perspective is integral to health research, care and policy.